This is evidenced by the fact that transfer of autologous activated T cells is required for the successful engraftment of CLL cells in murine models; and that efficient proliferation of CLL cells was observed after the engraftment of CD4+ T cells bearing a T cell receptor (TR) with CLL-unrelated specificity (6–8). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.